Selected article for: "clinical study and cohort study"
Author: Mingzhu Yin; Lijuan Zhang; Guangtong Deng; Chaofei Han; Minxue Shen; Hongyin Sun; Furong Zeng; Wei Zhang; Lan Chen; Qingqing Luo; Dujuan Yao; Min Wu; Shihuan Yu; Hui Chen; David Baud; Xiang Chen
Title: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Pregnancy In China: A Retrospective Cohort Study
  • Document date: 2020_4_11
    • ID: 6wolrfvk_4
    Snippet: For this retrospective cohort study, we reviewed clinical records, laboratory findings, and chest CT scans from 31 pregnant women and 35 non-pregnant women from Jan 28 to Feb 28, 2020 to evaluate the effects of SARS-CoV-2 infection during pregnancy. Inflammatory indices were used to assess the severity of COVID-19. Evidence of vertical transmission was determined by laboratory confirmation of SARS-CoV-2 in amniotic fluid, placenta, neonatal throa.....
    Document: For this retrospective cohort study, we reviewed clinical records, laboratory findings, and chest CT scans from 31 pregnant women and 35 non-pregnant women from Jan 28 to Feb 28, 2020 to evaluate the effects of SARS-CoV-2 infection during pregnancy. Inflammatory indices were used to assess the severity of COVID-19. Evidence of vertical transmission was determined by laboratory confirmation of SARS-CoV-2 in amniotic fluid, placenta, neonatal throat and anal swab and breastmilk samples.

    Search related documents:
    Co phrase search for related documents
    • amniotic fluid and cohort study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • amniotic fluid and laboratory confirmation: 1
    • amniotic fluid and neonatal throat: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • amniotic fluid and pregnant woman: 1, 2, 3, 4, 5, 6, 7, 8
    • amniotic fluid and retrospective cohort study: 1, 2, 3
    • amniotic fluid and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
    • amniotic fluid and severity assess: 1
    • amniotic fluid and vertical transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
    • amniotic fluid and vertical transmission evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • anal swab neonatal throat and cohort study: 1, 2
    • anal swab neonatal throat and laboratory confirmation: 1
    • anal swab neonatal throat and neonatal throat: 1, 2, 3, 4, 5, 6, 7
    • anal swab neonatal throat and retrospective cohort study: 1, 2
    • anal swab neonatal throat and SARS infection: 1
    • anal swab neonatal throat and severity assess: 1
    • anal swab neonatal throat and vertical transmission: 1, 2, 3, 4
    • anal swab neonatal throat and vertical transmission evidence: 1, 2
    • breastmilk sample and pregnant woman: 1
    • chest CT scan and clinical record: 1, 2